Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Psychotropic Medication Use and Postmenopausal Breast Cancer Risk.

George A, Sturgeon SR, Hankinson SE, Shadyab AH, Wallace RB, Reeves KW.

Cancer Epidemiol Biomarkers Prev. 2020 Jan;29(1):254-256. doi: 10.1158/1055-9965.EPI-19-0776. Epub 2019 Nov 4.

PMID:
31685559
2.

Urinary concentrations of phthalate biomarkers and weight change among postmenopausal women: a prospective cohort study.

Díaz Santana MV, Hankinson SE, Bigelow C, Sturgeon SR, Zoeller RT, Tinker L, Manson JAE, Calafat AM, Meliker JR, Reeves KW.

Environ Health. 2019 Mar 12;18(1):20. doi: 10.1186/s12940-019-0458-6.

3.

Urinary Phthalate Biomarker Concentrations and Postmenopausal Breast Cancer Risk.

Reeves KW, Díaz Santana M, Manson JE, Hankinson SE, Zoeller RT, Bigelow C, Sturgeon SR, Spiegelman D, Tinker L, Luo J, Chen B, Meliker J, Bonner MR, Cote ML, Cheng TD, Calafat AM.

J Natl Cancer Inst. 2019 Oct 1;111(10):1059-1067. doi: 10.1093/jnci/djz002.

4.

Dietary Intervention to Increase Fruit and Vegetable Consumption in Breastfeeding Women: A Pilot Randomized Trial Measuring Inflammatory Markers in Breast Milk.

Essa AR, Browne EP, Punska EC, Perkins K, Boudreau E, Wiggins H, Anderton DL, Sibeko L, Sturgeon SR, Arcaro KF.

J Acad Nutr Diet. 2018 Dec;118(12):2287-2295. doi: 10.1016/j.jand.2018.06.015. Epub 2018 Sep 10.

PMID:
30213617
5.

Antidepressant Use and Risk of Colorectal Cancer in the Women's Health Initiative.

Kiridly-Calderbank JF, Sturgeon SR, Kroenke CH, Reeves KW.

Cancer Epidemiol Biomarkers Prev. 2018 Aug;27(8):892-898. doi: 10.1158/1055-9965.EPI-17-1035. Epub 2018 May 22.

6.

Association of urinary levels of 6-sulfatoxymelatonin (aMT6s) with prevalent and incident hypertension.

Pérez-Caraballo AM, Ma Y, Ockene JK, Reeves KW, Balasubramanian R, Stanczyk FZ, Allison MA, Chen C, Wang L, Manson JE, Sturgeon SR.

Chronobiol Int. 2018 Aug;35(8):1115-1121. doi: 10.1080/07420528.2018.1461109. Epub 2018 May 11.

PMID:
29750588
7.

White blood cell DNA methylation and risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO).

Sturgeon SR, Pilsner JR, Arcaro KF, Ikuma K, Wu H, Kim SM, Chopra-Tandon N, Karpf AR, Ziegler RG, Schairer C, Balasubramanian R, Reckhow DA.

Breast Cancer Res. 2017 Aug 18;19(1):94. doi: 10.1186/s13058-017-0886-6.

8.

Relationships between Global DNA Methylation in Circulating White Blood Cells and Breast Cancer Risk Factors.

Chopra-Tandon N, Wu H, Arcaro KF, Sturgeon SR.

J Cancer Epidemiol. 2017;2017:2705860. doi: 10.1155/2017/2705860. Epub 2017 Apr 6. Review.

9.

Urinary levels of phthalate metabolites and cardiovascular disease mortality (NHANES, 1999-2008).

Sturgeon SR, Flynn D, Kaiser AB, Reeves KW.

Int J Hyg Environ Health. 2016 Nov;219(8):876-882. doi: 10.1016/j.ijheh.2016.07.006. Epub 2016 Jul 11.

PMID:
27475039
10.

Menopausal vasomotor symptoms and incident breast cancer risk in the Study of Women's Health Across the Nation.

Hart V, Sturgeon SR, Reich N, Sievert LL, Crawford SL, Gold EB, Avis NE, Reeves KW.

Cancer Causes Control. 2016 Nov;27(11):1333-1340. Epub 2016 Sep 28.

11.

Impact of incident diabetes on atherosclerotic cardiovascular disease according to statin use history among postmenopausal women.

Ma Y, Persuitte GM, Andrews C, Hovey KM, LaMonte MJ, Culver AL, Manson JE, Phillips LS, Liu S, Eaton C, Martin LW, Howard BV, Balasubramanian R, Bird CE, Ockene IS, Sturgeon SR, Ockene JK, Tinker L, Nassir R, Rossouw J.

Eur J Epidemiol. 2016 Aug;31(8):747-61. doi: 10.1007/s10654-016-0153-7. Epub 2016 May 17.

12.

Effects of Pomegranate Juice on Hormonal Biomarkers of Breast Cancer Risk.

Kapoor R, Ronnenberg A, Puleo E, Chatterton RT Jr, Dorgan JF, Seeram NP, Sturgeon SR.

Nutr Cancer. 2015;67(7):1113-9. doi: 10.1080/01635581.2015.1073756. Epub 2015 Sep 1.

PMID:
26327495
13.

The effect of change in body mass index on volumetric measures of mammographic density.

Hart V, Reeves KW, Sturgeon SR, Reich NG, Sievert LL, Kerlikowske K, Ma L, Shepherd J, Tice JA, Mahmoudzadeh AP, Malkov S, Sprague BL.

Cancer Epidemiol Biomarkers Prev. 2015 Nov;24(11):1724-30. doi: 10.1158/1055-9965.EPI-15-0330. Epub 2015 Aug 27.

14.

Coffee, tea, and melanoma risk among postmenopausal women.

Wu H, Reeves KW, Qian J, Sturgeon SR.

Eur J Cancer Prev. 2015 Jul;24(4):347-52. doi: 10.1097/CEJ.0000000000000093.

PMID:
25325307
15.

Perineal powder use and risk of ovarian cancer.

Houghton SC, Reeves KW, Hankinson SE, Crawford L, Lane D, Wactawski-Wende J, Thomson CA, Ockene JK, Sturgeon SR.

J Natl Cancer Inst. 2014 Sep 10;106(9). pii: dju208. doi: 10.1093/jnci/dju208. Print 2014 Sep.

16.

Using breast milk to assess breast cancer risk: the role of mass spectrometry-based proteomics.

Schneider SS, Aslebagh R, Ngounou Wetie AG, Sturgeon SR, Darie CC, Arcaro KF.

Adv Exp Med Biol. 2014;806:399-408. doi: 10.1007/978-3-319-06068-2_19. Review.

PMID:
24952194
17.

DNA methylation in paired breast epithelial and white blood cells from women undergoing reduction mammoplasty.

Sturgeon SR, Arcaro KF, Johnson MA, Balasubramanian R, Zorn M, Jerry DJ, Schneider SS.

Anticancer Res. 2014 Jun;34(6):2985-90.

PMID:
24922663
18.

Urinary levels of melatonin and risk of postmenopausal breast cancer: women's health initiative observational cohort.

Sturgeon SR, Doherty A, Reeves KW, Bigelow C, Stanczyk FZ, Ockene JK, Liu S, Manson JE, Neuhouser ML.

Cancer Epidemiol Biomarkers Prev. 2014 Apr;23(4):629-37. doi: 10.1158/1055-9965.EPI-13-1028. Epub 2014 Feb 7.

19.

Detection of promoter methylation of tumor suppressor genes in serum DNA of breast cancer cases and benign breast disease controls.

Sturgeon SR, Balasubramanian R, Schairer C, Muss HB, Ziegler RG, Arcaro KF.

Epigenetics. 2012 Nov;7(11):1258-67. doi: 10.4161/epi.22220. Epub 2012 Sep 17.

20.

Perineal powder use and risk of endometrial cancer in postmenopausal women.

Crawford L, Reeves KW, Luisi N, Balasubramanian R, Sturgeon SR.

Cancer Causes Control. 2012 Oct;23(10):1673-80. doi: 10.1007/s10552-012-0046-3. Epub 2012 Aug 9.

PMID:
22875750
21.

Sleep duration and endometrial cancer risk.

Sturgeon SR, Luisi N, Balasubramanian R, Reeves KW.

Cancer Causes Control. 2012 Apr;23(4):547-53. doi: 10.1007/s10552-012-9912-2. Epub 2012 Feb 24.

PMID:
22362059
22.

Caffeinated coffee, decaffeinated coffee and endometrial cancer risk: a prospective cohort study among US postmenopausal women.

Giri A, Sturgeon SR, Luisi N, Bertone-Johnson E, Balasubramanian R, Reeves KW.

Nutrients. 2011 Nov;3(11):937-50. doi: 10.3390/nu3110937. Epub 2011 Nov 2.

23.

Dietary intervention of flaxseed: effect on serum levels of IGF-1, IGF-BP3, and C-peptide.

Sturgeon SR, Volpe SL, Puleo E, Bertone-Johnson ER, Heersink J, Sabelawski S, Wähälä K, Bigelow C, Kurzer MS.

Nutr Cancer. 2011;63(3):376-80. doi: 10.1080/01635581.2011.535964.

PMID:
21462084
24.

Pomegranate and breast cancer: possible mechanisms of prevention.

Sturgeon SR, Ronnenberg AG.

Nutr Rev. 2010 Feb;68(2):122-8. doi: 10.1111/j.1753-4887.2009.00268.x. Review.

PMID:
20137057
25.

Effect of flaxseed consumption on urinary levels of estrogen metabolites in postmenopausal women.

Sturgeon SR, Volpe SL, Puleo E, Bertone-Johnson ER, Heersink J, Sabelawski S, Wahala K, Bigelow C, Kurzer MS.

Nutr Cancer. 2010;62(2):175-80. doi: 10.1080/01635580903305342.

PMID:
20099191
26.

Effect of dietary flaxseed on serum levels of estrogens and androgens in postmenopausal women.

Sturgeon SR, Heersink JL, Volpe SL, Bertone-Johnson ER, Puleo E, Stanczyk FZ, Sabelawski S, Wahala K, Kurzer MS, Bigelow C.

Nutr Cancer. 2008;60(5):612-8. doi: 10.1080/01635580801971864.

PMID:
18791924
27.

Relationship between calcium, lactose, vitamin D, and dairy products and ovarian cancer.

Koralek DO, Bertone-Johnson ER, Leitzmann MF, Sturgeon SR, Lacey JV Jr, Schairer C, Schatzkin A.

Nutr Cancer. 2006;56(1):22-30.

PMID:
17176214
28.

Serum concentrations of estrogens, sex hormone-binding globulin, and androgens and risk of breast cancer in postmenopausal women.

Adly L, Hill D, Sherman ME, Sturgeon SR, Fears T, Mies C, Ziegler RG, Hoover RN, Schairer C.

Int J Cancer. 2006 Nov 15;119(10):2402-7.

29.

Interrelationships between serum leptin, IGF-1, IGFBP3, C-peptide and prolactin and breast cancer risk in young women.

Falk RT, Brinton LA, Madigan MP, Potischman N, Sturgeon SR, Malone KE, Daling JR.

Breast Cancer Res Treat. 2006 Jul;98(2):157-65. Epub 2006 Feb 24.

PMID:
16502016
30.

Serum concentrations of estrogens, sex hormone binding globulin, and androgens and risk of breast hyperplasia in postmenopausal women.

Schairer C, Hill D, Sturgeon SR, Fears T, Mies C, Ziegler RG, Hoover RN, Sherman ME.

Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1660-5.

31.

Trends in breast cancer mortality rates by region of the United States, 1950-1999.

Sturgeon SR, Schairer C, Grauman D, El Ghormli L, Devesa S.

Cancer Causes Control. 2004 Dec;15(10):987-95.

PMID:
15801483
32.

Serum levels of sex hormones and breast cancer risk in premenopausal women: a case-control study (USA).

Sturgeon SR, Potischman N, Malone KE, Dorgan JF, Daling J, Schairer C, Brinton LA.

Cancer Causes Control. 2004 Feb;15(1):45-53.

PMID:
14970734
33.

Population-density and county-level variation in breast cancer mortality rates among white women residing in the Northeastern and Southern United States.

Sturgeon SR, Graubard BI, Schairer C, McAdams M, Hoover RN, Gail MH.

Cancer Causes Control. 2003 Dec;14(10):923-31.

PMID:
14750531
34.

Serum concentrations of IGF-I, IGFBP-3 and c-peptide and risk of hyperplasia and cancer of the breast in postmenopausal women.

Schairer C, Hill D, Sturgeon SR, Fears T, Pollak M, Mies C, Ziegler RG, Hoover RN, Sherman ME.

Int J Cancer. 2004 Feb 20;108(5):773-9.

35.

Estrogen replacement therapy and breast cancer survival in a large screening study.

Schairer C, Gail M, Byrne C, Rosenberg PS, Sturgeon SR, Brinton LA, Hoover RN.

J Natl Cancer Inst. 1999 Feb 3;91(3):264-70.

PMID:
10037105
36.

Serum concentrations of organochlorine compounds and endometrial cancer risk (United States).

Sturgeon SR, Brock JW, Potischman N, Needham LL, Rothman N, Brinton LA, Hoover RN.

Cancer Causes Control. 1998 Aug;9(4):417-24.

PMID:
9794174
37.

Evidence for a common etiology for endometrial carcinomas and malignant mixed mullerian tumors.

Zelmanowicz A, Hildesheim A, Sherman ME, Sturgeon SR, Kurman RJ, Barrett RJ, Berman ML, Mortel R, Twiggs LB, Wilbanks GD, Brinton LA.

Gynecol Oncol. 1998 Jun;69(3):253-7.

PMID:
9648597
38.

Analysis of histopathological features of endometrioid uterine carcinomas and epidemiologic risk factors.

Sturgeon SR, Sherman ME, Kurman RJ, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Brinton LA.

Cancer Epidemiol Biomarkers Prev. 1998 Mar;7(3):231-5.

39.

Intrauterine device use and endometrial cancer risk.

Sturgeon SR, Brinton LA, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Lurain JR.

Int J Epidemiol. 1997 Jun;26(3):496-500.

PMID:
9222773
40.

Second primary cancers after vulvar and vaginal cancers.

Sturgeon SR, Curtis RE, Johnson K, Ries L, Brinton LA.

Am J Obstet Gynecol. 1996 Mar;174(3):929-33.

PMID:
8633671
41.

Geographic variation in mortality from breast cancer among white women in the United States.

Sturgeon SR, Schairer C, Gail M, McAdams M, Brinton LA, Hoover RN.

J Natl Cancer Inst. 1995 Dec 20;87(24):1846-53.

PMID:
7494228
42.

Evidence of a healthy estrogen user survivor effect.

Sturgeon SR, Schairer C, Brinton LA, Pearson T, Hoover RN.

Epidemiology. 1995 May;6(3):227-31.

PMID:
7619927
43.

Menopausal estrogen and estrogen-progestin replacement therapy and risk of breast cancer (United States).

Schairer C, Byrne C, Keyl PM, Brinton LA, Sturgeon SR, Hoover RN.

Cancer Causes Control. 1994 Nov;5(6):491-500.

PMID:
7827235
44.

Associations between bladder cancer risk factors and tumor stage and grade at diagnosis.

Sturgeon SR, Hartge P, Silverman DT, Kantor AF, Linehan WM, Lynch C, Hoover RN.

Epidemiology. 1994 Mar;5(2):218-25.

PMID:
8172997
45.

Past and present physical activity and endometrial cancer risk.

Sturgeon SR, Brinton LA, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD.

Br J Cancer. 1993 Sep;68(3):584-9.

46.

Racial differences in ill defined cancer mortality in the United States and in the District of Columbia.

Schwartz E, Kofie VY, Sturgeon SR.

J Epidemiol Community Health. 1992 Aug;46(4):390-3.

47.

In situ and invasive vulvar cancer incidence trends (1973 to 1987).

Sturgeon SR, Brinton LA, Devesa SS, Kurman RJ.

Am J Obstet Gynecol. 1992 May;166(5):1482-5.

PMID:
1595803
48.

Diet and the risk of vulvar cancer.

Sturgeon SR, Ziegler RG, Brinton LA, Nasca PC, Mallin K, Gridley G.

Ann Epidemiol. 1991 Aug;1(5):427-37.

PMID:
1669523
49.

The impact of the Community Hospital Oncology Program (CHOP) on the quality of data reporting.

Sturgeon SR, Kerner JF, Mortenson LE.

Prog Clin Biol Res. 1986;216:131-41. No abstract available.

PMID:
3014556
50.

Utilization of local patient management guidelines and protocols in CHOP hospitals.

Kerner JF, Mortenson LE, Anderson PN, Enck R, Sturgeon SR.

Prog Clin Biol Res. 1986;216:117-29. No abstract available.

PMID:
3014555

Supplemental Content

Loading ...
Support Center